Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant positivity for BCOR immunohistochemistry in merkel cell carcinoma - a potential diagnostic pitfall. | Diagn Pathol | 2024 | 39334415 | PubTator, text mining | PubMed |
| The BCOR -rearranged sarcoma involving the lung: Diagnosis with clinical outcome and literature review. | Indian J Pathol Microbiol | 2024 | 39285667 | PubTator, text mining | PubMed |
| Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome. | Mol Biol Rep | 2024 | 39278886 | PubTator, text mining | PubMed |
| High-grade endometrial stromal sarcoma with BCOR rearrangements: clinicopathological analysis of five cases and literature reviews - an extension in understanding of morphological characteristics. | Int J Clin Exp Pathol | 2024 | 39262439 | PubTator, text mining | PubMed |
| Calcium modulates the tethering of BCOR-PRC1.1 enzymatic core to KDM2B via liquid-liquid phase separation. | Commun Biol | 2024 | 39256555 | PubTator, text mining | PubMed |
| Orbital Sarcoma with BCOR Genetic Alterations in the Pediatric Age Group. | Fetal Pediatr Pathol | 2024 | 39245644 | PubTator, text mining | PubMed |
| Erratum. | NMC Case Rep J | 2024 | 39224241 | PubTator, text mining | PubMed |
| Abstracts Presented at the 2024 WIN Symposium in Partnership with Burjeel Holdings: March 1-2, 2024, Abu Dhabi, United Arab Emirates. | J Immunother Precis Oncol | 2024 | 39219997 | PubTator, text mining | PubMed |
| Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations. | Hematology | 2024 | 39158486 | PubTator, text mining | PubMed |
| Epigenetic regulation of noncanonical menin targets modulates menin inhibitor response in acute myeloid leukemia. | Blood | 2024 | 39158067 | PubTator, text mining | PubMed |
Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation. | Br J Haematol | 2024 | 39138006 | PubTator, text mining | PubMed |
| The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study. | Leuk Lymphoma | 2024 | 39126311 | PubTator, text mining | PubMed |
| Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients. | Cancer Med | 2024 | 39126219 | PubTator, text mining | PubMed |
| The DNA methylome of pediatric brain tumors appears shaped by structural variation and predicts survival. | Nat Commun | 2024 | 39117669 | PubTator, text mining | PubMed |
| Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China. | Int J Cancer | 2024 | 39109820 | PubTator, text mining | PubMed |
| 1q jumping translocation as a biomarker in myeloid malignancy: frequently mutated genes associated with bad prognosis and low survival. | Exp Hematol Oncol | 2024 | 39090734 | PubTator, text mining | PubMed |
| The Combined Immunohistochemical Expression of GLI1 and BCOR in Synovial Sarcomas for the Identification of Three Risk Groups and Their Prognostic Outcomes: A Study of 52 Patients. | Int J Mol Sci | 2024 | 39062853 | PubTator, text mining | PubMed |
| Case report: Metastatic refractory undifferentiated small round-cell sarcoma successfully treated with surufatinib and camrelizumab. | Front Oncol | 2024 | 39055564 | PubTator, text mining | PubMed |
| We need to talk-how muscle stem cells communicate. | Front Cell Dev Biol | 2024 | 39050890 | PubTator, text mining | PubMed |
| Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing. | Am J Clin Nutr | 2024 | 39025327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=12